Clinical trial
Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease
NCT00287170 · Teva GTC, Industry · Completed
Key facts
| NCT number | NCT00287170 |
|---|---|
| Title | Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease |
| Official title | Pilot, Open-Label, Randomized, Parallel Group Study to Evaluate Clinical/ and Immunological Efficacy/Safety of Locally Delivered 6-MP or Calcitriol vs Purinethol in Non-Steroid Dependent Patients With Active CD |
| Lead sponsor | Teva GTC, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | Delayed Release 6MP or Calcitriol vs. Purinethol |
| Enrollment | 15 |
| Start date | Jul 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Feb 6, 2006 |
| Last update posted | Jul 8, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: